Immunome Inc (IMNM)

Mar 12, 2026

Loss Report: Is Immunome Inc forming a breakout pattern2026 Risk Factors & Weekly Stock Breakout Alerts - baoquankhu1.vn

Mar 12, 2026

Mar 12, 2026

Bienaime buys Immunome (IMNM) shares worth $43,670 - Investing.com Nigeria

Mar 12, 2026

Mar 12, 2026

Insider Buying: Jean Bienaime Acquires Additional Shares of Immu - GuruFocus

Mar 12, 2026

Mar 12, 2026

Immunome (NASDAQ:IMNM) Director Acquires $21,550.00 in Stock - MarketBeat

Mar 12, 2026

Mar 11, 2026

Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing - AOL.com

Mar 11, 2026

Mar 11, 2026

A Look At Immunome (IMNM) Valuation After Narrower 2025 Loss And New US$156 Million Shelf Registration - simplywall.st

Mar 11, 2026

Mar 11, 2026

Immunome: Upcoming NDA, Valuation, And Investment Case (NASDAQ:IMNM) - Seeking Alpha

Mar 11, 2026

Mar 08, 2026

(IMNM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Mar 08, 2026

Mar 07, 2026

Immunome (NASDAQ:IMNM) Downgraded by Wall Street Zen to "Sell" - MarketBeat

Mar 07, 2026

Mar 07, 2026

Is Immunome Inc forming a breakout patternJuly 2025 Analyst Calls & Growth Focused Stock Pick Reports - baoquankhu1.vn

Mar 07, 2026

Mar 06, 2026

Did Reduced 2025 Losses and NDA Plans Just Shift Immunome's (IMNM) Investment Narrative? - Yahoo Finance

Mar 06, 2026

Mar 06, 2026

Whale Trades: How do insiders feel about Immunome IncMarket Sentiment Review & Entry and Exit Point Strategies - baoquankhu1.vn

Mar 06, 2026

Mar 06, 2026

HC Wainwright Brokers Raise Earnings Estimates for Immunome - MarketBeat

Mar 06, 2026

Mar 06, 2026

Immunome (IMNM) TTM Net Loss Of US$212 Million Reinforces Bearish Profitability Narratives - Sahm

Mar 06, 2026

Mar 05, 2026

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com

Mar 05, 2026

Mar 05, 2026

HC Wainwright Analysts Boost Earnings Estimates for Immunome - MarketBeat

Mar 05, 2026

Mar 04, 2026

IMNM: Stephens & Co. Lowers Price Target to $30, Maintains Overw - GuruFocus

Mar 04, 2026

Mar 04, 2026

Immunome (IMNM): Craig-Hallum Raises Price Target to $36.00 and - GuruFocus

Mar 04, 2026

Mar 04, 2026

Immunome (NASDAQ:IMNM) Price Target Raised to $36.00 - MarketBeat

Mar 04, 2026

Mar 04, 2026

Stephens Cuts Immunome (NASDAQ:IMNM) Price Target to $30.00 - MarketBeat

Mar 04, 2026

Mar 04, 2026

Decoding Immunome Inc (IMNM): A Strategic SWOT Insight - GuruFocus

Mar 04, 2026

Mar 03, 2026

Immunome (IMNM) Reports Wider Losses and Revenue Decline - GuruFocus

Mar 03, 2026

Mar 03, 2026

Immunome 2025 Net Loss Narrows - marketscreener.com

Mar 03, 2026

Mar 03, 2026

Immunome (IMNM) Projects Strong Cash Position and Promising Drug Developments - GuruFocus

Mar 03, 2026

Mar 03, 2026

Earnings Flash (IMNM) Immunome Posts Full Year 2025 Loss $2.43, vs. FactSet Est of $2.24 Loss - marketscreener.com

Mar 03, 2026

Mar 03, 2026

Immunome: Q4 Earnings Insights - Benzinga

Mar 03, 2026

Mar 03, 2026

IMNM: Net loss improved to $212.4M in 2025, with $653.5M cash supporting late-stage oncology pipeline - TradingView

Mar 03, 2026

Mar 03, 2026

Immunome (IMNM) 2025 10-K: Phase 3 varegacestat data and ADC pipeline - Stock Titan

Mar 03, 2026

Mar 03, 2026

Immunome (IMNM) posts 2025 loss but scores major Phase 3 cancer win - Stock Titan

Mar 03, 2026

Mar 03, 2026

Immunome Reports Full Year 2025 Financial Results and Provides Business Update - Business Wire

Mar 03, 2026

Mar 03, 2026

TD Asset Management Inc Purchases 95,750 Shares of Immunome, Inc. $IMNM - MarketBeat

Mar 03, 2026

Mar 03, 2026

How Immunome’s Oncology Pivot and Varegacestat NDA Push Could Impact Immunome (IMNM) Investors - simplywall.st

Mar 03, 2026

Mar 03, 2026

IMNM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026

Mar 02, 2026

Immunome, Inc. (IMNM) Sets Sights on $1B Opportunity amid Pipeline Development - Insider Monkey

Mar 02, 2026

Feb 28, 2026

11 Best Cancer Stocks to Invest In Now - Insider Monkey

Feb 28, 2026

Feb 27, 2026

Immunome, Inc. (IMNM) Investor Outlook: Exploring a Promising 60% Upside in the Biotech Sector - DirectorsTalk Interviews

Feb 27, 2026

Feb 26, 2026

Private Capital Advisors Inc. Has $1.38 Million Stake in Immunome, Inc. $IMNM - MarketBeat

Feb 26, 2026

Feb 24, 2026

Assessing Immunome (IMNM) Valuation After Recent Share Price Pullback - Yahoo Finance

Feb 24, 2026

Feb 23, 2026

Immunome to Present at Upcoming March 2026 Investor Conferences - BioSpace

Feb 23, 2026

Feb 23, 2026

First Week of October 16th Options Trading For Immunome (IMNM) - Nasdaq

Feb 23, 2026

Feb 23, 2026

Immunome to Present at Upcoming Investor Conferences - The Joplin Globe

Feb 23, 2026

Feb 23, 2026

Biotech Immunome to face investors at two March conferences - Stock Titan

Feb 23, 2026

Feb 22, 2026

Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120% - Yahoo Finance

Feb 22, 2026

Feb 21, 2026

Risk Analysis: Is Immunome Inc part of any ETF2025 Year in Review & Technical Pattern Based Signals - baoquankhu1.vn

Feb 21, 2026

Feb 21, 2026

Immunome, Inc. $IMNM Shares Acquired by NEOS Investment Management LLC - MarketBeat

Feb 21, 2026

Feb 20, 2026

Immunome, Inc. (IMNM) - DirectorsTalk Interviews

Feb 20, 2026

Feb 19, 2026

Market Fear: Can Immunome Inc be the next market leaderShort Setup & Weekly Breakout Watchlists - baoquankhu1.vn

Feb 19, 2026

Feb 18, 2026

Is Immunome, Inc. (IMNM) the best booming stock to buy right now? - MSN

Feb 18, 2026

Feb 17, 2026

Jim Cramer on Immunome: "If you want to speculate on it, fine" - MSN

Feb 17, 2026

Feb 17, 2026

Should You Buy Immunome Inc (IMNM) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI

Feb 17, 2026

Feb 17, 2026

Redmile Group (IMNM) discloses 5.2% Immunome stake via managed funds - Stock Titan

Feb 17, 2026

Feb 16, 2026

Brokers Issue Forecasts for Immunome FY2025 Earnings - MarketBeat

Feb 16, 2026